Cyclerion Therapeutics (CYCN) Receivables (2020 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Receivables of $1.0 million for Q4 2025, up 79.86% year-over-year from $556000.0 in Q4 2024, and up 900.0% quarter-over-quarter from $100000.0 in Q3 2025.
Cyclerion Therapeutics (CYCN) Receivables (2020 - 2025) Analysis & Trends
Cyclerion Therapeutics' Receivables history runs 6 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- In Q4 2025, Receivables rose 79.86% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 79.86% YoY), while the FY2025 annual figure was $1.0 million, up 79.86% from the prior year.
- Receivables for Q4 2025 stood at $1.0 million, up from $100000.0 in the prior quarter.
- The five-year high for Receivables was $1.0 million in Q4 2025, with the low at $44000.0 in Q3 2024.
- The 5-year median for Receivables is $227000.0 (2022), against an average of $302846.2.
- The sharpest annual moves came in 2023 and 2025: Receivables tumbled 57.71% in 2023, then jumped 127.27% in 2025.
- Cyclerion Therapeutics' Receivables stood at $100000.0 in 2021, then fell by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then surged by 479.17% to $556000.0 in 2024, then soared by 79.86% to $1.0 million in 2025.
- Business Quant data shows CYCN's Receivables at $1.0 million in Q4 2025, $100000.0 in Q3 2025, and $525000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | - |
| 10 | Cyclerion Therapeutics | 13.38 Mn | 10.14 Mn | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 525,000.00 |
| Mar 31, 2025 | 581,000.00 |
| Dec 31, 2024 | 556,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 96,000.00 |
| Sep 30, 2022 | 227,000.00 |
| Jun 30, 2022 | 227,000.00 |
| Mar 31, 2022 | 227,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Dec 31, 2020 | 127,000.00 |